New immune process identified that may alleviate Alzheimer’s disease
Calcium-sensitive switch boosts cancer drugs’ efficacy
$120m investment to grow talent and innovation in Virginia
Potential of enzymatic single-stranded DNA for non-viral gene editing
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly
Amgen reveals cardiovascular drug results
Pila Pharma’s capital raise oversubscribed by 293% to fund obesity studies